You just read:

AcelRx Pharmaceuticals Reports Successful Outcome of ZALVISO Phase 3 IAP312 Study on Device Functionality

News provided by

AcelRx Pharmaceuticals, Inc.

Aug 01, 2017, 07:00 ET